Skip to main content
Journal cover image

18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.

Publication ,  Journal Article
Subramaniam, RM; Wilcox, B; Aubry, MC; Jett, J; Peller, PJ
Published in: J Med Imaging Radiat Oncol
April 2009

Malignant pleural mesothelioma (MPM) is the most common primary pleural tumor and its incidence is rising. Its diagnosis, staging and response assessment are challenging for imaging. Integrated positron emission tomography (PET)/CT increases the accuracy of overall staging in patients with mesothelioma and improves the selection of patients for curative surgical resection. It is particularly useful in identifying occult distant metastases. It may be used to predict prognosis and to assess the metabolic response to therapy.

Duke Scholars

Published In

J Med Imaging Radiat Oncol

DOI

EISSN

1754-9485

Publication Date

April 2009

Volume

53

Issue

2

Start / End Page

160 / 169

Location

Australia

Related Subject Headings

  • Tomography, X-Ray Computed
  • Radiopharmaceuticals
  • Positron-Emission Tomography
  • Pleural Neoplasms
  • Nuclear Medicine & Medical Imaging
  • Mesothelioma
  • Humans
  • Fluorodeoxyglucose F18
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Subramaniam, R. M., Wilcox, B., Aubry, M. C., Jett, J., & Peller, P. J. (2009). 18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma. J Med Imaging Radiat Oncol, 53(2), 160–169. https://doi.org/10.1111/j.1754-9485.2009.02058.x
Subramaniam, R. M., B. Wilcox, M. C. Aubry, J. Jett, and P. J. Peller. “18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.J Med Imaging Radiat Oncol 53, no. 2 (April 2009): 160–69. https://doi.org/10.1111/j.1754-9485.2009.02058.x.
Subramaniam RM, Wilcox B, Aubry MC, Jett J, Peller PJ. 18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma. J Med Imaging Radiat Oncol. 2009 Apr;53(2):160–9.
Subramaniam, R. M., et al. “18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma.J Med Imaging Radiat Oncol, vol. 53, no. 2, Apr. 2009, pp. 160–69. Pubmed, doi:10.1111/j.1754-9485.2009.02058.x.
Subramaniam RM, Wilcox B, Aubry MC, Jett J, Peller PJ. 18F-fluoro-2-deoxy-D-glucose positron emission tomography and positron emission tomography/computed tomography imaging of malignant pleural mesothelioma. J Med Imaging Radiat Oncol. 2009 Apr;53(2):160–169.
Journal cover image

Published In

J Med Imaging Radiat Oncol

DOI

EISSN

1754-9485

Publication Date

April 2009

Volume

53

Issue

2

Start / End Page

160 / 169

Location

Australia

Related Subject Headings

  • Tomography, X-Ray Computed
  • Radiopharmaceuticals
  • Positron-Emission Tomography
  • Pleural Neoplasms
  • Nuclear Medicine & Medical Imaging
  • Mesothelioma
  • Humans
  • Fluorodeoxyglucose F18
  • 3211 Oncology and carcinogenesis
  • 3202 Clinical sciences